Skip to main content
Clinical Trials/NCT04355598
NCT04355598UnknownPhase 4

Comparative Safety and Efficacy of Cervical Lidocaine-Prilocaine Cream Versus Glyceryl Trinitrate Cream on Pain Perception During Levonorgestrel- Intrauterine Device Insertion Among Nulliparous Women: a Randomized Double-blind Controlled Trial

Cairo University0 sites195 target enrollmentStarted: April 30, 2020Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 4
Enrollment
195
Primary Endpoint
pain during LNG-IUD insertion

Study Overview

Brief Summary

the aim of the present study is to compare safety and efficacy of cervical Lidocaine-Prilocaine cream versus glyceryl trinitrate cream on pain perception during levonorgestrel- intrauterine device insertion among nulliparous women: a randomized double-blind controlled trial

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • young and adolescent women requesting LNG-IUD insertion

Exclusion Criteria

  • parous women and contraindications to LNG-IUD placement or to the study drugs.

Arms & Interventions

Lidocaine-Prilocaine cream

Experimental

2 mL of the Lidocaine-Prilocaine cream will be placed on the anterior lip of the cervix by a Q-tip applicator, followed by 2 mL will be introduced in the cervical canal 7 minutes prior to IUD insertion

Intervention: Lidocaine-Prilocaine cream (Drug)

glyceryl trinitrate cream

Active Comparator

2 mL of the glyceryl trinitrate cream will be placed on the anterior lip of the cervix by a Q-tip applicator, followed by 2 mL will be introduced in the cervical canal 7 minutes prior to IUD insertion

Intervention: glyceryl trinitrate cream (Drug)

placebo cream

Placebo Comparator

2 mL of the placebo cream will be placed on the anterior lip of the cervix by a Q-tip applicator, followed by 2 mL will be introduced in the cervical canal 7 minutes prior to IUD insertion

Intervention: placebo cream (Drug)

Outcomes

Primary Outcomes

pain during LNG-IUD insertion

Time Frame: 5 minutes

pain during LNG-IUD insertion evaluated by 10 cm Visual analog scale where 0=no pain and 10=worst pain imaginable

Secondary Outcomes

  • duration of the procedure(10 minutes)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Ahmed Samy aly ashour

assistant professor obstetrics and gynecology

Cairo University

Similar Trials